In prostate cancer, Krześlak et al. [60] found a significant association between MT2A SNP and Cd, Zn, Cu and Pb levels, suggesting that SNP polymorphisms may affect MT2A gene expression and be associated with metal accumulation. Here, MT2A is linked to prostate carcinoma.